Holdings of ROBO Global Healthcare Technology and Innovation ETF
ISIN US3015057231
EXCHANGE TRADED CONCEPTS TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 53.3M $ including 53.2M $ in equities, 99.7 %
- Positions
- 59 in 11 countries
- Top ten
- 22.6 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Axogen Inc | 38,954 | 1.7M $ | 3.16 % |
| 2 | Arrowhead Pharmaceuticals Inc | 18,591 | 1.4M $ | 2.56 % |
| 3 | Twist Bioscience Corp | 21,324 | 1.2M $ | 2.34 % |
| 4 | Glaukos Corp | 8,259 | 1.2M $ | 2.22 % |
| 5 | Natera Inc | 5,611 | 1.2M $ | 2.17 % |
| 6 | Tempus AI Inc | 20,430 | 1.1M $ | 2.13 % |
| 7 | Novocure Ltd | 71,645 | 1.1M $ | 2.04 % |
| 8 | Alnylam Pharmaceuticals Inc | 3,468 | 1.1M $ | 2.01 % |
| 9 | Guardant Health Inc | 12,193 | 1.1M $ | 1.99 % |
| 10 | Thermo Fisher Scientific Inc | 2,213 | 1.1M $ | 1.99 % |
| 11 | Vertex Pharmaceuticals Inc | 2,435 | 1M $ | 1.95 % |
| 12 | Illumina Inc | 8,210 | 1M $ | 1.95 % |
| 13 | Intuitive Surgical Inc | 2,267 | 1M $ | 1.95 % |
| 14 | GRAIL Inc | 18,597 | 1M $ | 1.90 % |
| 15 | Globus Medical Inc | 10,979 | 990.1K $ | 1.86 % |
| 16 | Penumbra Inc | 3,021 | 986.3K $ | 1.85 % |
| 17 | LivaNova PLC | 16,373 | 984K $ | 1.84 % |
| 18 | Edwards Lifesciences Corp | 11,784 | 984K $ | 1.84 % |
| 19 | CareDx Inc | 47,248 | 983.2K $ | 1.84 % |
| 20 | Stryker Corp | 3,048 | 960.5K $ | 1.80 % |
| 21 | Lonza Group AG | 1,563 | 957.7K $ | 1.80 % |
| 22 | United Therapeutics Corp | 1,674 | 956.4K $ | 1.79 % |
| 23 | Siemens Healthineers AG | 23,296 | 953.2K $ | 1.79 % |
| 24 | Regeneron Pharmaceuticals, Inc. | 1,346 | 951.7K $ | 1.78 % |
| 25 | Incyte Corp | 9,967 | 949.6K $ | 1.78 % |
| 26 | IRhythm Holdings Inc | 7,332 | 947K $ | 1.78 % |
| 27 | Artivion Inc | 26,421 | 946.7K $ | 1.77 % |
| 28 | Adaptive Biotechnologies Corp | 65,865 | 928.7K $ | 1.74 % |
| 29 | IQVIA Holdings Inc | 5,832 | 923.6K $ | 1.73 % |
| 30 | Medpace Holdings Inc | 2,197 | 919.8K $ | 1.72 % |
| 31 | Koninklijke Philips NV | 34,911 | 916.9K $ | 1.72 % |
| 32 | Boston Scientific Corp | 15,586 | 897.9K $ | 1.68 % |
| 33 | Danaher Corp | 5,006 | 895.8K $ | 1.68 % |
| 34 | Novanta Inc | 6,865 | 889.2K $ | 1.67 % |
| 35 | Bio-Rad Laboratories Inc | 3,129 | 876.5K $ | 1.64 % |
| 36 | Veracyte Inc | 26,611 | 876K $ | 1.64 % |
| 37 | Eurofins Scientific SE | 12,641 | 875.2K $ | 1.64 % |
| 38 | JD Health International Inc | 149,900 | 868K $ | 1.63 % |
| 39 | Agilent Technologies Inc | 7,491 | 865.6K $ | 1.62 % |
| 40 | Bristol-Myers Squibb Co | 13,556 | 821.4K $ | 1.54 % |
| 41 | Tecan Group AG | 5,358 | 806.4K $ | 1.51 % |
| 42 | Roche Holding AG | 1,955 | 795.9K $ | 1.49 % |
| 43 | Charles River Laboratories International Inc | 4,749 | 792.9K $ | 1.49 % |
| 44 | Abbott Laboratories | 8,729 | 792.5K $ | 1.49 % |
| 45 | Integra LifeSciences Holdings Corp | 72,586 | 765.1K $ | 1.43 % |
| 46 | Becton Dickinson & Co | 4,921 | 733.4K $ | 1.38 % |
| 47 | GE HealthCare Technologies Inc | 11,868 | 722K $ | 1.35 % |
| 48 | Align Technology Inc | 4,087 | 719.4K $ | 1.35 % |
| 49 | Moderna Inc | 15,139 | 695.5K $ | 1.30 % |
| 50 | CONMED Corp | 18,673 | 684.6K $ | 1.28 % |
| 51 | BioMarin Pharmaceutical Inc | 12,555 | 676.8K $ | 1.27 % |
| 52 | QIAGEN NV | 19,472 | 673.3K $ | 1.26 % |
| 53 | DiaSorin SpA | 9,749 | 663.5K $ | 1.24 % |
| 54 | Omnicell Inc | 15,970 | 661.5K $ | 1.24 % |
| 55 | Smith & Nephew PLC | 38,562 | 595.8K $ | 1.12 % |
| 56 | Revvity Inc | 6,695 | 579.9K $ | 1.09 % |
| 57 | PeptiDream Inc | 70,700 | 519.3K $ | 0.97 % |
| 58 | Veeva Systems Inc | 3,271 | 510.2K $ | 0.96 % |
| 59 | Alibaba Health Information Technology Ltd | 914,000 | 509.9K $ | 0.96 % |
Sector breakdown
- Health care 36.4 %
- Technology 1.0 %
- Unattributed 62.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 84.1 %
- EUR 6.4 %
- CHF 4.8 %
- HKD 2.6 %
- GBP 1.1 %
- JPY 1.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 80.4 %
- Switzerland 4.8 %
- Hong Kong SAR China 2.6 %
- Jersey 2.0 %
- Germany 1.8 %
- Netherlands 1.7 %
- Canada 1.7 %
- Luxembourg 1.6 %
- Italy 1.2 %
- United Kingdom 1.1 %
- Japan 1.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 46 | 42.8M $ | 80.37 % |
| 2 | Switzerland | 3 | 2.6M $ | 4.81 % |
| 3 | Hong Kong SAR China | 2 | 1.4M $ | 2.59 % |
| 4 | Jersey | 1 | 1.1M $ | 2.05 % |
| 5 | Germany | 1 | 953.2K $ | 1.79 % |
| 6 | Netherlands | 1 | 916.9K $ | 1.72 % |
| 7 | Canada | 1 | 889.2K $ | 1.67 % |
| 8 | Luxembourg | 1 | 875.2K $ | 1.65 % |
| 9 | Italy | 1 | 663.5K $ | 1.25 % |
| 10 | United Kingdom | 1 | 595.8K $ | 1.12 % |
| 11 | Japan | 1 | 519.3K $ | 0.98 % |
Cite this page
Titelia. "Holdings of ROBO Global Healthcare Technology and Innovation ETF". https://titelia.com/en/funds/S000065730